Under the plan, free generic drugs would be given at the public health facilities in states, according to a Health Ministry official.
The generics are off-patent medicines which cost much less than the patented drugs. Most of the commonly used drugs are generics in nature.
"This year, a new and ambitious initiative has been proposed for supply of free generic drugs in the public health facilities in the states," the official said, adding that it would help in expanding access to medicines.
The proposal which is a part of the 12th Plan involves Rs 20,000 crore outlay from the Centre and about Rs 7,000 crore from the states.
The Indian pharma industry has hailed the move saying, "any attempt by the government to provide medicines free of cost to the weaker sections of society is always welcome. We will support this initiative by the government," said D G Shah, secretary general of the Indian Pharmaceutical Alliance (IPA).
It would also be a boost for the Rs 1.10 lakh crore domestic industry which thrives on generic drugs, not only in India but also in the export market.
"The Government has been sanctioning funds under various programmes, including the National Rural Health Mission (NRHM). Last year a special initiative was undertaken to provide free drugs to women for deliveries in public hospitals and infants," the Health Ministry official said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
